Holder evidence
25
SEC ownership of Hoth Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001711786.
Largest current holder
Robb Knie
13D/G signal
—
Latest evidence
26 May 2026
- Symbol
- HOTH on Nasdaq
- Ownership evidence mix
- 3/4/5 and 13F
- Largest current holder
- Robb Knie
- Latest evidence date
- 26 May 2026
- CIK
- 0001711786
- Location
- Hoboken, NJ
Ownership snapshot
1 fact
Issuer identity
2 facts
Ownership snapshot
Top shareholders of Hoth Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Largest current holder
Robb Knie
13D/G signal
—
Evidence rows
25
Latest as of
26 May 2026
3/4/5
13F
Highest disclosed value: $662,338
Showing 1-8 of 25 holder rows.
Quick read
Robb Knie has the largest disclosed position value at $662.3K.
Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Disclosed position value
Top 5
Robb Knie
$662.3K
GEODE CAPITAL MANAGEMENT, LLC
$180K
UBS Group AG
$132.7K
VANGUARD CAPITAL MANAGEMENT LLC
$108.9K
VANGUARD FIDUCIARY TRUST CO
$70.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 25 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Robb Knie |
3/4/5
CEO and President, Director
|
—
mixed-class rows
|
$662,338
1,097,387 shares
mixed-class rows
|
— | 26 May 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$180,028
214,244 shares
|
— | 31 Mar 2026 |
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$132,701
157,977 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
class O/S missing
|
$108,940
129,691 shares
|
— | 31 Mar 2026 |
| VANGUARD FIDUCIARY TRUST CO |
13F
Company
|
—
class O/S missing
|
$70,827
84,318 shares
|
— | 31 Mar 2026 |
| STATE STREET CORP |
13F
Company
|
—
class O/S missing
|
$53,728
63,939 shares
|
— | 31 Mar 2026 |
| NORTHERN TRUST CORP |
13F
Company
|
—
class O/S missing
|
$35,338
42,054 shares
|
— | 31 Mar 2026 |
| Lido Advisors, LLC |
13F
Company
|
—
class O/S missing
|
$32,772
39,000 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 01 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-7 of 7 reporting-owner rows connected to Hoth Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
7
Largest current holder
Robb Knie
Net 12M change
$0
Latest report
26 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Robb Knie | CEO and President, Director | $662,338 | Mixed | 26 May 2026 | ||
| Graig Springer | Director | Mixed | 14 Jan 2025 | |||
| Stefanie Johns | Chief Scientific Officer | Mixed | 16 Mar 2022 | |||
| Christopher Michael Camarra | Director | Mixed | 26 May 2026 | |||
| David Sarnoff | Director | Mixed | 26 May 2026 | |||
| Wayne Linsley | Director | Mixed | 26 May 2026 | |||
| Jeff Pavell | Director | Mixed | 26 May 2026 |
Recent insider transactions for Hoth Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Wayne Linsley | HOTH | Options | Award | 75,000 | 75,000 | 26 May 2026 | Direct | |||
| Robb Knie | HOTH | Options | Award | 550,000 | 550,000 | 26 May 2026 | Direct | |||
| David Sarnoff | HOTH | Options | Award | 75,000 | 75,000 | 26 May 2026 | Direct | |||
| Christopher Michael Camarra | HOTH | Options | Award | 75,000 | 75,000 | 26 May 2026 | Direct | |||
| Jeff Pavell | HOTH | Options | Award | 75,000 | 75,000 | 26 May 2026 | Direct | |||
| Robb Knie | HOTH | Common Stock | Tax liability | -36.2% | -310,744 | 547,387 | 28 Aug 2025 | Direct | ||
| Robb Knie | HOTH | Common Stock | Award | 1376.2% | 800,000 | 858,131 | 27 Aug 2025 | Direct |
* indicates a reported price that failed the local validity check.